Podiatrists in East Liverpool, OH Accepting Medicare

9 Podiatrists found. Showing 1 - 9

Dr. David A Kutlick, DPM Podiatrist - Primary Podiatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 15700 State Route 170, Suite B, East Liverpool, OH 43920 Phone: 330-385-2227    Fax: 330-385-4242

Sean Patrick Hayes, DPM Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 425 W 5th St, East Liverpool, OH 43920 Phone: 330-386-2791

Nathan Moore Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 425 W 5th St, East Liverpool, OH 43920 Phone: 330-386-2790

James Christopher Rousher Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 425 W 5th St, East Liverpool, OH 43920 Phone: 330-385-7200

Footcare Associates, Inc. Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 15700 State Route 170 Ste B, East Liverpool, OH 43920 Phone: 330-385-2227    Fax: 330-385-4242

Ankle And Foot Care Centers Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 16844 Saint Clair Ave, East Liverpool, OH 43920 Phone: 330-385-2413

Anna Doan, DPM Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 425 W 5th St, East Liverpool, OH 43920 Phone: 330-385-7200

Ankle And Foot Care Centers Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 332 W 6th St, East Liverpool, OH 43920 Phone: 877-479-9449

Abena Framso Agyepong Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 425 W 5th St, East Liverpool, OH 43920 Phone: 614-372-9130

News Archive

FDA grants clearance for HPβCD treatment for Niemann Pick Type C disease

Children's Hospital & Research Center Oakland announced today that the US Food and Drug Administration (FDA) has granted clearance of an Investigational New Drug (IND) application to introduce Trappsol Cyclo (Hydroxypropyl Beta Cyclodextrin or HPβCD) into the brains of six year old identical twin girls dying of a rare brain-destroying cholesterol disease called Niemann Pick Type C (NPC).

CorMedix's Neutrolin catheter lock solution receives CE Mark approval

CorMedix Inc. today announced that it has received CE Mark approval for Neutrolin, a catheter lock solution, for patients with central venous catheters on hemodialysis secondary to advanced chronic kidney disease.

Experts to discuss latest trends in treatments, diagnostic techniques for managing HCC

Today, world renowned experts have assembled in Dubrovnik, Croatia to discuss the latest trends in treatment and cutting edge research in diagnostic techniques that will shape the future management of hepatocellular carcinoma - the third most common cause of cancer-related death globally, and a leading cause of death among patients with liver cirrhosis.

European survey sheds light on decision-making criteria of physicians treating advanced lung cancer patients

Boehringer Ingelheim announced today results of a new European survey investigating therapy goals, prescribing habits and decision-making criteria of physicians treating patients with advanced lung cancer with adenocarcinoma histology after first-line chemotherapy.

Read more Medical News

› Verified 7 days ago